Advances in Analytical Methodology of Prostate Cancer Markers

insertion of intraprostate gold fiducial markers in prostate cancer treatment

Advances in prostate cancer immunotherapies.

Prostate cancer is a major cause of mortality in men in the Western world. Although treatment of early stage prostate cancer with radiation therapy or prostatectomy is efficient in most cases, some patients develop a fatal hormone-refractory disease. Treatments in this case are limited to aggressive chemotherapies, which can reduce serum prostate-specific antigen (PSA) levels in some patients. ...

investigation of (meta)discourse markers in elt coursebooks

the present study aimed to investigate representation of discourse markers and metadiscourse markers in conversations and readings of general elt coursebook series used in the language centers of iran. to this aim, four elt coursebooks popularly taught in language centers of this country were analyzed based on fung and carter’s (2007) framework regarding discourse markers and hyland’s (2005) fr...

Tumoral Markers in Prostate Cancer

In Mexico, in 70% of cases, the prostate cancer (PCa) is found in advanced stage. PCa currently occupies second place in frequency of cancer in men, surpassed only by skin cancer, and is the second principal cause of death in men after of lung cancer (Hall et al., 2005). Reactive oxygen species (ROS) such as superoxide (O2 −) and hydrogen peroxide (H2O2) are found in a large number of tumors a...

Advances in biological markers for cancer.

The following serum tumor markers are elevated above normal levels in 50 percent or more of patients with various malignant neoplasms: Alpha-fetoprotein in yolk sac tumors, hepatomas, retinoblastomas, embryonal carcinomas, breast carcinomas, and carcinomas of uterine cervix; Carcinoembryonic antigen in colon carcinomas, choriocarcinomas, pancreatic carcinomas, medullary thyroid carcinomas, oste...